{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-008512","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.063971+00:00","generated_at":"2026-05-19T16:01:39.066050+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Xilio Therapeutics elects Dr. Akintunde Bello to Board of Directors","bullets":["Board increased to ten directors; Dr. Bello elected as Class II director effective June 10, 2025.","Term expires at 2026 annual meeting; appointed to Nominating and Corporate Governance Committee.","Compensation follows standard non-employee director terms as described in the 2025 proxy statement.","Dr. Bello will enter into the company's standard indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-008512","json":"https://secwatch.observer/filing/0001558370-25-008512.json","markdown":"https://secwatch.observer/filing/0001558370-25-008512.md","text":"https://secwatch.observer/filing/0001558370-25-008512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/0001558370-25-008512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/xlo-20250610x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T16:01:39.066050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"95b59958b5","claim":"Akintunde Bello was elected as Class II director at Xilio Therapeutics, Inc..","evidence_excerpt":"elected Akintunde Bello, Ph.D., as a Class II director of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840233/000155837025008512/0001558370-25-008512-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}